These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5451898)

  • 1. [Effect of a beta-adrenergic blocking agent in myocardial infarct mortality].
    Lane JC; Rocha JC; dos Filho I; Frazatto C; Paladino S
    Arq Bras Cardiol; 1970 Feb; 23(1):45-8. PubMed ID: 5451898
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
    Saini RK; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antifibrillatory effect of mexiletine (Kö 1173) in experimentally induced myocardial infarct].
    Henning B; Merx W; de Bakker JM; Effert S
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1232-3. PubMed ID: 1029966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy with beta receptor blockers in myocardial infarct].
    Hohnloser SH; Klingenheben T
    Z Kardiol; 1994 Nov; 83(11):824-9. PubMed ID: 7825372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Omega-3 fatty acids after myocardial infarct: decreasing mortality by anti-arrhythmia effects].
    Sellmayer A; Theisen K; Weber PC
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1542-6. PubMed ID: 11190766
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of bencyclane on the course of experimental myocardial infarction].
    Dzavachisvili NA; Gibradze TA; Cagareli ZG; Kipiani MK; Asitasvili SG; Kobaladze AS
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1368+. PubMed ID: 5536640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lidocaine prophylaxis in acute myocardial infarct].
    Foelske H; Berndt H
    Z Arztl Fortbild (Jena); 1984; 78(5):165-6. PubMed ID: 6719948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A; Herlitz J
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of sudden death in acute myocardial ischaemia.
    Fejfar Z; Vrána M; Horák O; Trcka V; Kristan L; Blazek Z; Korál V; Sychra T
    Czech Med; 1980; 3(1):28-35. PubMed ID: 6102022
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxyphedrin in acute myocardial infarct].
    Kucuruza I; Antunes VG; Oliveira CA; Coutinho CL; Rabello L; Guzman O
    Rev Bras Med; 1971 Jun; 28(6):298-303. PubMed ID: 5127240
    [No Abstract]   [Full Text] [Related]  

  • 19. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.
    Hjalmarson A; Herlitz J; Holmberg S; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Circulation; 1983 Jun; 67(6 Pt 2):I26-32. PubMed ID: 6342837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.
    Joseph X; Jordan AW; Balazs T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):239-49. PubMed ID: 6330819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.